Nuvation Bio Inc. (NYSE: NUVB) last traded at $6.93, up 1.46% on the session. The quote above updates while this page is open; the figures below are drawn from Nuvation Bio Inc.’s own filings and are restated only when a new one is published.
Nuvation Bio Inc. trades on NYSE under the ticker NUVB. Its market capitalisation is $2.43 billion.
Valuation measures for Nuvation Bio Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $2.43B |
|---|---|
| Enterprise value | $2.67B |
| Price / sales | 14.32 |
| Price / book | 9.58 |
| Beta | 1.67 |
Trailing-twelve-month figures tagged in Nuvation Bio Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $169.90M |
|---|---|
| Net income (TTM) | -$149.83M |
| EPS (TTM) | -$0.440 |
| Gross margin | 8.54% |
| Operating margin | -81.00% |
| Return on equity | -59.02% |
| Cash | $258.60M |
Range and volume for NUVB over the past 52 weeks.
| 52-week high | $9.75 |
|---|---|
| 52-week low | $2.84 |
| Volume | 4.83M |
| Average volume | 6.77M |
| Previous close | $6.83 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.